What does azstarys — cost, amortization mean?

The periodic non-cash expense recognized to reflect the consumption of the Azstarys intangible asset's value over time. This metric is essential for understanding the impact of asset-related depreciation on the company's operating profitability.

Collegium Pharmaceutical, Inc. (COLL) Azstarys — Cost, Amortization

Screener

Other product segments

Jornay PM

$20.96M0.0%

Belbuca

$18.85M0.0%

Symproic and other

$7.29M0.0%

Symproic

$1.82M0.0%

Similar metrics at other companies

CSVCemetery — Cost, Amortization

$3.13M+39.6%

CSVFuneral Home — Cost, Amortization

$0—

RBBNAmortization Of Acquired Technology — Cost Of Goods And Services Sold Amortization

$4.56M-15.3%

PRSUService — Cost Of Goods And Services Sold Amortization

$700K0.0%

TONXMarket Live — Cost Of Goods And Services Sold Amortization

$0-100%

AVAVMw — Cost Of Goods And Services Sold Amortization

$231.25K-27.1%

Other financials

Income statement

See full

Revenue$199.9M+6.3%

Gross profit$110.3M+1.8%

Operating income$3.7M-89.5%

Net income-$15.1M-226%

EPS (diluted)-$0.46-235%

Balance sheet

See full

Cash & equivalents$150.4M+8.8%

Total debt$5.0M-19.8%

Total equity$311.9M+34.3%

Total assets$2.1B+34.1%

Cash flow

See full

Operating cash flow$71.3M-1.5%

CapEx$496.0K+663%

Free cash flow$70.8M-2.1%

Valuation

See full

Market cap$1.16B+21.2%

Enterprise value$1.01B+23.0%

P/E24.2×-2.2×

P/S1.4×+0.1×

Profitability

See full

Gross margin60%+3.3pp

Operating margin19.5%+1.1pp

Net margin5.9%+0.8pp

FCF margin40.6%+10.8pp

Returns & leverage

See full

Return on equity17.6%+1.4pp

Debt / equity0×0.0×

Current ratio1×-0.2×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSoldAmortization.

The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026.

Filed: Aug 6, 2026, 7:34 AM EDT
Fiscal quarter: Q2 FY2026
Calendar quarter: Q2 2026
Accession: 0001628280-26-053851

Line item	Three Months Ended June 30, 2026	Three Months Ended June 30, 2025	Six Months Ended June 30, 2026	Six Months Ended June 30, 2025
Jornay PM	$20,957	$20,957	$41,914	$41,914
Belbuca	18,849	18,849	37,698	37,697
Nucynta Products	13,846	13,846	27,692	27,692
Azstarys	7,480	—	7,480	—
Symproic	1,821	1,821	3,642	3,643
Total amortization expense	$62,953	$55,473	$118,426	$110,946

Item 1. Condensed Consolidated Financial Statements (Unaudited).

FAQ

What is Collegium Pharmaceutical, Inc.'s azstarys — cost, amortization?: Collegium Pharmaceutical, Inc. (COLL) reported azstarys — cost, amortization of $7.48M in Q2 2026.
What does azstarys — cost, amortization mean?: The periodic non-cash expense recognized to reflect the consumption of the Azstarys intangible asset's value over time. This metric is essential for understanding the impact of asset-related depreciation on the company's operating profitability.